# Leuprolide Acetate

NDC: 83634-454
Generic name: leuprolide acetate
Labeler / Manufacturer: Avenacy, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: KIT
Routes: SUBCUTANEOUS
Marketing started: 20250315
Marketing ended: 20260630
FDA application: ANDA217957

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83634-454"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83634-454
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=15003c37-6e91-4c79-a85c-3d03343b53f9